These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 31112072)
1. Lack of Pharmacokinetic Basis of Weight-Based Dosing and Intra-Operative Re-Dosing with Cefazolin Surgical Prophylaxis in Obese Patients: Implications for Antibiotic Stewardship. Blum S; Cunha CB; Cunha BA Surg Infect (Larchmt); 2019 Sep; 20(6):439-443. PubMed ID: 31112072 [TBL] [Abstract][Full Text] [Related]
2. Optimal Cefazolin Prophylactic Dosing for Bariatric Surgery: No Need for Higher Doses or Intraoperative Redosing. Chen X; Brathwaite CE; Barkan A; Hall K; Chu G; Cherasard P; Wang S; Nicolau DP; Islam S; Cunha BA Obes Surg; 2017 Mar; 27(3):626-629. PubMed ID: 27520693 [TBL] [Abstract][Full Text] [Related]
3. Does current cefazolin dosing achieve adequate tissue and blood concentrations in obese women undergoing cesarean section? Kram JJF; Greer DM; Cabrera O; Burlage R; Forgie MM; Siddiqui DS Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():334-341. PubMed ID: 28122314 [TBL] [Abstract][Full Text] [Related]
5. Evaluating the Duration of Prophylactic Post-Operative Antibiotic Agents after Open Reduction Internal Fixation for Closed Fractures. Crist BD; Oladeji LO; Della Rocca GJ; Volgas DA; Stannard JP; Greenberg DD Surg Infect (Larchmt); 2018 Jul; 19(5):535-540. PubMed ID: 29781787 [TBL] [Abstract][Full Text] [Related]
6. Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women. Swank ML; Wing DA; Nicolau DP; McNulty JA Am J Obstet Gynecol; 2015 Sep; 213(3):415.e1-8. PubMed ID: 26003059 [TBL] [Abstract][Full Text] [Related]
7. A Retrospective Exploration of Pre-operative Antibiotic Prophylaxis with Cefazolin in Cesarean Sections: Implications for Obstetrics and Gynecologic Surgery. Abdel Halim AS; Ali MAM; Al Mamari R; Al Raisi F; Boufahja F; Chaudhary AA; Hegazy WAH Surg Infect (Larchmt); 2024 Sep; 25(7):513-520. PubMed ID: 38957977 [No Abstract] [Full Text] [Related]
9. Plasma and tissue cefazolin concentrations in obese patients undergoing cesarean delivery and receiving differing pre-operative doses of drug. Stitely M; Sweet M; Slain D; Alons L; Holls W; Hochberg C; Briggs F Surg Infect (Larchmt); 2013 Oct; 14(5):455-9. PubMed ID: 23859672 [TBL] [Abstract][Full Text] [Related]
10. Effects of maternal obesity on tissue concentrations of prophylactic cefazolin during cesarean delivery. Pevzner L; Swank M; Krepel C; Wing DA; Chan K; Edmiston CE Obstet Gynecol; 2011 Apr; 117(4):877-882. PubMed ID: 21422859 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic Cefazolin Dosing and Surgical Site Infections: Does the Dose Matter in Obese Patients? Hussain Z; Curtain C; Mirkazemi C; Gadd K; Peterson GM; Zaidi STR Obes Surg; 2019 Jan; 29(1):159-165. PubMed ID: 30267229 [TBL] [Abstract][Full Text] [Related]
12. Validation of a Dosing Strategy for Cefazolin for Surgery Requiring Cardiopulmonary Bypass. Hollis AL; Heil EL; Nicolau DP; Odonkor P; Dowling TC; Thom KA Surg Infect (Larchmt); 2015 Dec; 16(6):829-32. PubMed ID: 26291478 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic Cefazolin Dosing in Women With Body Mass Index >35 kg·m-2 Undergoing Cesarean Delivery: A Pharmacokinetic Study of Plasma and Interstitial Fluid. Eley VA; Christensen R; Ryan R; Jackson D; Parker SL; Smith M; van Zundert AA; Wallis SC; Lipman J; Roberts JA Anesth Analg; 2020 Jul; 131(1):199-207. PubMed ID: 32250982 [TBL] [Abstract][Full Text] [Related]
14. Association between Pre-Operative Cefazolin Dose and Surgical Site Infection in Obese Patients. Peppard WJ; Eberle DG; Kugler NW; Mabrey DM; Weigelt JA Surg Infect (Larchmt); 2017; 18(4):485-490. PubMed ID: 27906601 [TBL] [Abstract][Full Text] [Related]
15. Comparative total and unbound pharmacokinetics of cefazolin administered by bolus versus continuous infusion in patients undergoing major surgery: a randomized controlled trial. Naik BI; Roger C; Ikeda K; Todorovic MS; Wallis SC; Lipman J; Roberts JA Br J Anaesth; 2017 Jun; 118(6):876-882. PubMed ID: 28505360 [TBL] [Abstract][Full Text] [Related]
16. Cefazolin tissue concentrations with a prophylactic dose administered before sleeve gastrectomy in obese patients: a single centre study in 116 patients. Cinotti R; Dumont R; Ronchi L; Roquilly A; Atthar V; Grégoire M; Planche L; Letessier E; Dailly E; Asehnoune K Br J Anaesth; 2018 Jun; 120(6):1202-1208. PubMed ID: 29793587 [TBL] [Abstract][Full Text] [Related]
17. Effect of Body Weight on Cefazolin and Vancomycin Trabecular Bone Concentrations in Patients Undergoing Total Joint Arthroplasty. Sharareh B; Sutherland C; Pourmand D; Molina N; Nicolau DP; Schwarzkopf R Surg Infect (Larchmt); 2016 Feb; 17(1):71-7. PubMed ID: 26397726 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery. Young OM; Shaik IH; Twedt R; Binstock A; Althouse AD; Venkataramanan R; Simhan HN; Wiesenfeld HC; Caritis SN Am J Obstet Gynecol; 2015 Oct; 213(4):541.e1-7. PubMed ID: 26103528 [TBL] [Abstract][Full Text] [Related]
19. Regional Intraosseous Administration of Prophylactic Antibiotics is More Effective Than Systemic Administration in a Mouse Model of TKA. Young SW; Roberts T; Johnson S; Dalton JP; Coleman B; Wiles S Clin Orthop Relat Res; 2015 Nov; 473(11):3573-84. PubMed ID: 26224291 [TBL] [Abstract][Full Text] [Related]
20. Higher versus Lower Dose of Cefotetan or Cefoxitin for Surgical Prophylaxis in Patients Weighing One Hundred Twenty Kilograms or More. Banoub M; Curless MS; Smith JM; Jarrell AS; Cosgrove SE; Rock C; Avdic E Surg Infect (Larchmt); 2018 Jul; 19(5):504-509. PubMed ID: 29717917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]